Participating in vaccine research for COVID-19 in Senegal: trust and information
Domaine:
healthcareCréateur:
ValMouIbrAma
Éditeur:
ope
Hôte:
Abstract
This research aims to understand the level and determinants of people’s willingness to participate in a vaccine trial for COVID-19 in Senegal. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years of age. Only 44.3% of the participants wanted to participate in a vaccine trial for COVID-19, with females intending to participate more than males. Participants who intended to be vaccinated against COVID-19 (OR = 6.48, 95% CI [4.12-10.4]) and who thought that being infected with the coronavirus would have a significant impact on their health (OR = 2.34, 95% CI [1.57, 3.51]) were more likely to agree to take part in the COVID-19 vaccine research. Confidence in the vaccine, health personnel, and government in the fight against the pandemic are key factors in intending to participate in vaccine research in Senegal.
Similaires
COVID-19 Vaccine Hesitancy and Trust in Government in NigeriaCovid-19 vaccine perceptions in Senegal and in Mali: a mixed approachDeterminants of COVID-19 Vaccine Acceptability in Mozambique: The Role of Institutional TrustDo we trust the government? Attributes of COVID-19 vaccine hesitancy and acceptance in NigeriaCOVID-19 in SenegalA Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa